Skip to content
Review

Microglia in Alzheimer's disease: Insights into disease progression and therapy.

2026 · Advances in Immunology · Vol 171, pp. 283-306 · 0 citations
Medicine

TL;DR

This chapter provides a comprehensive synthesis of microglial biology across multiple interfaces, including transcriptomic, lipid-associated metabolic, cell senescence, and metabolic reprogramming, and positions microglia biology as a metabolically plastic, spatially organized immune-regulated microenvironment that can efficiently aid in reprogramming and AD therapeutics.

View source

Similar papers

Review Aug 2026

The role of microglia glucose metabolism reprogramming in Alzheimer's disease treatment

This review systematically outlines the fundamental characteristics of microglial glucose metabolism and focuses on how the dynamic metabolic reprogramming it undergoes during AD progression regulates microglial immune behavior and inflammatory responses.

Qing-Yu Cao, Meng-Meng Shen, Yan Liu et al. · 0 citations
Open access Aug 2026

Plasticity of human microglia and brain perivascular macrophages in aging and Alzheimer’s disease

It is shown that a disease-associated microglial subtype, characterized by elevated GPNMB expression and enriched for polygenic AD risk, expands with AD pathology and shows increased phagocytic activity, and MITF is identified as an upstream regulator required to maintain this microglial state.

Donghoon Lee, James M. Vicari, Christian Porras et al. · 1 citation
Review 2026

Microglia-centered cellular crosstalk in neurodegeneration.

This chapter focuses on the diversification of neurodegenerative CNS microglial states, the interaction of microglia with neurons, glial cells, adaptive immune cells, and the vasculature, and how this framework provides a basis for therapeutic strategies aimed at modulating, replacing, or reprogramming microglia in neu...

Hao Huang, E. Mass · 0 citations
Review Open access Aug 2026

Microglia-mediated neuroinflammation in Alzheimer’s disease: mechanisms and emerging therapeutic targets

A “cellular state–pathological network–therapeutic window” framework is proposed and the roles of microglia in amyloid-β plaque seeding and compaction, NLRP3 inflammasome activation, mitochondrial DNA–cGAS–STING signaling, complement-mediated synaptic engulfment, and bidirectional microglia–tau feedback are systematica...

Lian-Jing Xu, Ying Zhang, Li Jiang et al. · 0 citations
Aug 2026

An ApoE-Associated Low-Inflammatory Microglial State Emerges After Inflammatory Challenge in Alzheimer's Disease Mice.

A distinct microglial state is identified that provides new insights into the dynamic role of microglia in AD and is associated with the phagocytosis of dystrophic neurites and was recapitulated in vitro using an efferocytosis-based model.

W. Cai, Xiaoli Pan, T. Qian et al. · 0 citations
Review 2026

Microglia extracellular traps (MiETs) in Neurodegeneration: Mechanisms, Evidence Gaps, and Untapped Therapeutic Promise.

This work situates MiET formation within the broader microglial functional repertoire and focuses on how ET-dominant responses may compromise homeostatic or neuroprotective roles, expanding the conceptual framework for microglial pathogenicity and inviting future mechanistic and translational research.

Lipika Sha, Sushmita Jha · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.